Documentos relacionados

1. Optimization and validation of a bioanalytical HPLC-UV technique for simultaneous determination of underivatized phenylalanine and tyrosine in the blood for phenylketonuria diagnosis and monitoring.
2. Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan.
3. Predicting factors of neurodevelopmental performance in children with phenylketonuria.
4. Long-term comparative effectiveness of pegvaliase versus medical nutrition therapy with and without sapropterin in adults with phenylketonuria.
5. Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need.
6. Mandatory versus voluntary consent for newborn screening?
7. Towards precision medicine for phenylketonuria: The effect of restoring a strict metabolic control in adult patients with early-treated phenylketonuria.
8. Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria.
9. Two-year interim safety and efficacy of pegvaliase in Japanese adults with phenylketonuria.
10. Benchmark Examination of Blood Amino Acids Patterns in Phenylketonuria Neonates and Young Children on Phenylalanine-Restricted Dietary Treatment.